Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension (Q33613468)

28 July 2017

title

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension (English)

1 reference

28 July 2017

main subject

arterial hypertension

0 references

lung transplant

1 reference

inferred from title

pulmonary hypertension

1 reference

Higenbottam TW

1

1 reference

28 July 2017

Spiegelhalter D

2

1 reference

28 July 2017

Scott JP

3

1 reference

28 July 2017

Fuster V

4

1 reference

28 July 2017

Dinh-Xuan AT

5

1 reference

28 July 2017

Caine N

6

1 reference

28 July 2017

Wallwork J

7

1 reference

28 July 2017

language of work or name

1 reference

1 October 1993

1 reference

28 July 2017

published in

British Heart Journal

1 reference

28 July 2017

volume

70

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

366-370

1 reference

Haemodynamic changes induced by prostacyclin in man.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Biology and therapeutic potential of prostacyclin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Noninvasive assessment of hemodynamic improvement during chronic vasodilator therapy in obliterative pulmonary hypertension.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Primary pulmonary hypertension. A national prospective study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Single lung transplantation for primary pulmonary hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Pulmonary hypertension in a lupus clinic: experience with twenty-four patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Improved survival after heart-lung transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Is it ethical to administer vasodilator drugs to patients with primary pulmonary hypertension?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025334

Primary pulmonary hypertension

30 October 2018

1 reference

12 December 2020

Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma

1 reference

12 December 2020

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

12 December 2020

The case for treatment of selected patients with primary pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes

1 reference

12 December 2020

The kingdom of the near-dead. The shortened unnatural life history of primary pulmonary hypertension

1 reference

12 December 2020

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry

1 reference

12 December 2020

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

12 December 2020

Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.70.4.366

1 reference

28 July 2017

1 reference

28 July 2017

1 reference